 | • レポートコード：QYR9NV18029 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、炎症性腸疾患療法の世界市場について調査・分析し、炎症性腸疾患療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（潰瘍性大腸炎、クローン病、その他）、用途別（病院、医学研究機関、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の炎症性腸疾患療法市場動向 ・主要企業別マーケットシェア ・炎症性腸疾患療法の種類別市場規模2014-2019 （潰瘍性大腸炎、クローン病、その他） ・炎症性腸疾患療法の用途別市場規模2014-2019 （病院、医学研究機関、その他） ・炎症性腸疾患療法の北米市場：主要企業・種類別/用途別市場規模 ・炎症性腸疾患療法のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・炎症性腸疾患療法の中国市場：主要企業・種類別/用途別市場規模 ・炎症性腸疾患療法の日本国内市場：主要企業・種類別/用途別市場規模 ・炎症性腸疾患療法の東南アジア市場：主要企業・種類別/用途別市場規模 ・炎症性腸疾患療法のインド市場：主要企業・種類別/用途別市場規模 ・炎症性腸疾患療法の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Johnson & Johnson、AbbVie、Takeda Pharmaceutical Company、Abbott、Celgene Corporation、Innovate Biopharma、Cosmo Pharmaceuticals、Gilead Sciences、Pfizer） ・炎症性腸疾患療法の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn’s disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not clear, clinical symptoms are not specific, easy to be confused with other diseases, so the diagnosis is more difficult.Once misdiagnosis is caused by mistreatment, the result is mild but not cured, serious is life-threatening.The diagnosis of inflammatory bowel disease mainly includes the collection of clinical history, colonoscopy, imaging and mucosal histology.In 2018, the global Inflammatory Bowel Disease Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Inflammatory Bowel Disease Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Inflammatory Bowel Disease Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Johnson & Johnson
AbbVie
Takeda Pharmaceutical Company
Abbott
Celgene Corporation
Innovate Biopharma
Cosmo Pharmaceuticals
Gilead Sciences
Pfizer
Market segment by Type, the product can be split into
Ulcerative Colitis
Crohns Disease
Others
Market segment by Application, split into
Hospital
Medical Research Organization
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Inflammatory Bowel Disease Therapy status, future forecast, growth opportunity, key market and key players.
To present the Inflammatory Bowel Disease Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Inflammatory Bowel Disease Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Ulcerative Colitis
1.4.3 Crohns Disease
1.4.4 Others
1.5 Market by Application
1.5.1 Global Inflammatory Bowel Disease Therapy Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Medical Research Organization
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Inflammatory Bowel Disease Therapy Market Size
2.2 Inflammatory Bowel Disease Therapy Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease Therapy Market Size by Regions (2019-2025)
2.2.2 Inflammatory Bowel Disease Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Inflammatory Bowel Disease Therapy Market Size by by Players
3.1.1 Global Inflammatory Bowel Disease Therapy Revenue by by Players (2014-2019)
3.1.2 Global Inflammatory Bowel Disease Therapy Revenue Market Share by by Players (2014-2019)
3.1.3 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Inflammatory Bowel Disease Therapy Key Players Head office and Area Served
3.3 Key Players Inflammatory Bowel Disease Therapy Product/Solution/Service
3.4 Date of Enter into Inflammatory Bowel Disease Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Inflammatory Bowel Disease Therapy Market Size by Type (2014-2019)
4.2 Global Inflammatory Bowel Disease Therapy Market Size by Application (2014-2019)
5 North America
5.1 North America Inflammatory Bowel Disease Therapy Market Size (2014-2019)
5.2 Inflammatory Bowel Disease Therapy Key Players in North America
5.3 North America Inflammatory Bowel Disease Therapy Market Size by Type
5.4 North America Inflammatory Bowel Disease Therapy Market Size by Application
6 Europe
6.1 Europe Inflammatory Bowel Disease Therapy Market Size (2014-2019)
6.2 Inflammatory Bowel Disease Therapy Key Players in Europe
6.3 Europe Inflammatory Bowel Disease Therapy Market Size by Type
6.4 Europe Inflammatory Bowel Disease Therapy Market Size by Application
7 China
7.1 China Inflammatory Bowel Disease Therapy Market Size (2014-2019)
7.2 Inflammatory Bowel Disease Therapy Key Players in China
7.3 China Inflammatory Bowel Disease Therapy Market Size by Type
7.4 China Inflammatory Bowel Disease Therapy Market Size by Application
8 Japan
8.1 Japan Inflammatory Bowel Disease Therapy Market Size (2014-2019)
8.2 Inflammatory Bowel Disease Therapy Key Players in Japan
8.3 Japan Inflammatory Bowel Disease Therapy Market Size by Type
8.4 Japan Inflammatory Bowel Disease Therapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Inflammatory Bowel Disease Therapy Market Size (2014-2019)
9.2 Inflammatory Bowel Disease Therapy Key Players in Southeast Asia
9.3 Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Type
9.4 Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Application
10 India
10.1 India Inflammatory Bowel Disease Therapy Market Size (2014-2019)
10.2 Inflammatory Bowel Disease Therapy Key Players in India
10.3 India Inflammatory Bowel Disease Therapy Market Size by Type
10.4 India Inflammatory Bowel Disease Therapy Market Size by Application
11 Central & South America
11.1 Central & South America Inflammatory Bowel Disease Therapy Market Size (2014-2019)
11.2 Inflammatory Bowel Disease Therapy Key Players in Central & South America
11.3 Central & South America Inflammatory Bowel Disease Therapy Market Size by Type
11.4 Central & South America Inflammatory Bowel Disease Therapy Market Size by Application
12 International Players Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Details
12.1.2 Company Description and Business Overview
12.1.3 Inflammatory Bowel Disease Therapy Introduction
12.1.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019))
12.1.5 Johnson & Johnson Recent Development
12.2 AbbVie
12.2.1 AbbVie Company Details
12.2.2 Company Description and Business Overview
12.2.3 Inflammatory Bowel Disease Therapy Introduction
12.2.4 AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.2.5 AbbVie Recent Development
12.3 Takeda Pharmaceutical Company
12.3.1 Takeda Pharmaceutical Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Inflammatory Bowel Disease Therapy Introduction
12.3.4 Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.3.5 Takeda Pharmaceutical Company Recent Development
12.4 Abbott
12.4.1 Abbott Company Details
12.4.2 Company Description and Business Overview
12.4.3 Inflammatory Bowel Disease Therapy Introduction
12.4.4 Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.4.5 Abbott Recent Development
12.5 Celgene Corporation
12.5.1 Celgene Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Inflammatory Bowel Disease Therapy Introduction
12.5.4 Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.5.5 Celgene Corporation Recent Development
12.6 Innovate Biopharma
12.6.1 Innovate Biopharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Inflammatory Bowel Disease Therapy Introduction
12.6.4 Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.6.5 Innovate Biopharma Recent Development
12.7 Cosmo Pharmaceuticals
12.7.1 Cosmo Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Inflammatory Bowel Disease Therapy Introduction
12.7.4 Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.7.5 Cosmo Pharmaceuticals Recent Development
12.8 Gilead Sciences
12.8.1 Gilead Sciences Company Details
12.8.2 Company Description and Business Overview
12.8.3 Inflammatory Bowel Disease Therapy Introduction
12.8.4 Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.8.5 Gilead Sciences Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Inflammatory Bowel Disease Therapy Introduction
12.9.4 Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.9.5 Pfizer Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Inflammatory Bowel Disease Therapy Key Market Segments
Table Key Players Inflammatory Bowel Disease Therapy Covered
Table Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Ulcerative Colitis Figures
Table Key Players of Ulcerative Colitis
Figuer Crohns Disease Figures
Table Key Players of Crohns Disease
Figuer Others Figures
Table Key Players of Others
Table Global Inflammatory Bowel Disease Therapy Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Inflammatory Bowel Disease Therapy Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Medical Research Organization Case Studies
Figure Other Case Studies
Figure Inflammatory Bowel Disease Therapy Report Years Considered
Figure Global Inflammatory Bowel Disease Therapy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Inflammatory Bowel Disease Therapy Market Size by Regions 2019-2025 (Million US$)
Table Global Inflammatory Bowel Disease Therapy Market Size by Regions 2019-2025 (Million US$)
Table Global Inflammatory Bowel Disease Therapy Market Share by Regions 2014-2019
Figure Global Inflammatory Bowel Disease Therapy Market Share by Regions 2014-2019
Figure Global Inflammatory Bowel Disease Therapy Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Inflammatory Bowel Disease Therapy Revenue by by Players (2014-2019) (Million US$)
Table Global Inflammatory Bowel Disease Therapy Market Share by by Players (2014-2019)
Figure Global Inflammatory Bowel Disease Therapy Market Share by by Players in 2018
Table Global Inflammatory Bowel Disease Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Inflammatory Bowel Disease Therapy Product/Solution/Service
Table Date of Enter into Inflammatory Bowel Disease Therapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Inflammatory Bowel Disease Therapy Market Size by Type (2014-2019) (Million US$)
Table Global Inflammatory Bowel Disease Therapy Market Size Share by Type (2014-2019)
Figure Global Inflammatory Bowel Disease Therapy Market Size Market Share by Type (2014-2019)
Table Global Inflammatory Bowel Disease Therapy Market Size by Application (2014-2019) (Million US$)
Table Global Inflammatory Bowel Disease Therapy Market Size Share by Application (2014-2019)
Figure Global Inflammatory Bowel Disease Therapy Market Size Market Share by Application (2014-2019)
Figure Global Inflammatory Bowel Disease Therapy Revenue Market Share by Application in 2018
Figure North America Inflammatory Bowel Disease Therapy Market Size 2014-2019 (Million US$)
Table North America Key Players Inflammatory Bowel Disease Therapy Revenue (2018-2019) (Million US$)
Table North America Key Players Inflammatory Bowel Disease Therapy Market Share (2018-2019)
Table North America Inflammatory Bowel Disease Therapy Market Size by Type 2014-2019 (Million US$)
Table North America Inflammatory Bowel Disease Therapy Market Share by Type 2014-2019
Table North America Inflammatory Bowel Disease Therapy Market Size by Application 2014-2019 (Million US$)
Table North America Inflammatory Bowel Disease Therapy Market Share by Application 2014-2019
Figure Europe Inflammatory Bowel Disease Therapy Market Size 2014-2019 (Million US$)
Table Europe Key Players Inflammatory Bowel Disease Therapy Revenue (2018-2019) (Million US$)
Table Europe Key Players Inflammatory Bowel Disease Therapy Market Share (2018-2019)
Table Europe Inflammatory Bowel Disease Therapy Market Size by Type 2014-2019 (Million US$)
Table Europe Inflammatory Bowel Disease Therapy Market Share by Type 2014-2019
Table Europe Inflammatory Bowel Disease Therapy Market Size by Application 2014-2019 (Million US$)
Table Europe Inflammatory Bowel Disease Therapy Market Share by Application 2014-2019
Figure China Inflammatory Bowel Disease Therapy Market Size 2014-2019 (Million US$)
Table China Key Players Inflammatory Bowel Disease Therapy Revenue (2018-2019) (Million US$)
Table China Key Players Inflammatory Bowel Disease Therapy Market Share (2018-2019)
Table China Inflammatory Bowel Disease Therapy Market Size by Type 2014-2019 (Million US$)
Table China Inflammatory Bowel Disease Therapy Market Share by Type 2014-2019
Table China Inflammatory Bowel Disease Therapy Market Size by Application 2014-2019 (Million US$)
Table China Inflammatory Bowel Disease Therapy Market Share by Application 2014-2019
Figure Japan Inflammatory Bowel Disease Therapy Market Size 2014-2019 (Million US$)
Table Japan Key Players Inflammatory Bowel Disease Therapy Revenue (2018-2019) (Million US$)
Table Japan Key Players Inflammatory Bowel Disease Therapy Market Share (2018-2019)
Table Japan Inflammatory Bowel Disease Therapy Market Size by Type 2014-2019 (Million US$)
Table Japan Inflammatory Bowel Disease Therapy Market Share by Type 2014-2019
Table Japan Inflammatory Bowel Disease Therapy Market Size by Application 2014-2019 (Million US$)
Table Japan Inflammatory Bowel Disease Therapy Market Share by Application 2014-2019
Figure Southeast Asia Inflammatory Bowel Disease Therapy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Inflammatory Bowel Disease Therapy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Inflammatory Bowel Disease Therapy Market Share (2018-2019)
Table Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Inflammatory Bowel Disease Therapy Market Share by Type 2014-2019
Table Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Inflammatory Bowel Disease Therapy Market Share by Application 2014-2019
Figure India Inflammatory Bowel Disease Therapy Market Size 2014-2019 (Million US$)
Table India Key Players Inflammatory Bowel Disease Therapy Revenue (2018-2019) (Million US$)
Table India Key Players Inflammatory Bowel Disease Therapy Market Share (2018-2019)
Table India Inflammatory Bowel Disease Therapy Market Size by Type 2014-2019 (Million US$)
Table India Inflammatory Bowel Disease Therapy Market Share by Type 2014-2019
Table India Inflammatory Bowel Disease Therapy Market Size by Application 2014-2019 (Million US$)
Table India Inflammatory Bowel Disease Therapy Market Share by Application 2014-2019
Figure Central & South America Inflammatory Bowel Disease Therapy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Inflammatory Bowel Disease Therapy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Inflammatory Bowel Disease Therapy Market Share (2018-2019)
Table Central & South America Inflammatory Bowel Disease Therapy Market Size by Type 2014-2019 (Million US$)
Table Central & South America Inflammatory Bowel Disease Therapy Market Share by Type 2014-2019
Table Central & South America Inflammatory Bowel Disease Therapy Market Size by Application 2014-2019 (Million US$)
Table Central & South America Inflammatory Bowel Disease Therapy Market Share by Application 2014-2019
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
Table Johnson & Johnson Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
Figure AbbVie Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
Table AbbVie Recent Development
Table Takeda Pharmaceutical Company Company Details
Table Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
Figure Takeda Pharmaceutical Company Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
Table Takeda Pharmaceutical Company Recent Development
Table Abbott Company Details
Table Abbott Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
Figure Abbott Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
Table Abbott Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
Figure Celgene Corporation Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
Table Celgene Corporation Recent Development
Table Innovate Biopharma Company Details
Table Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
Figure Innovate Biopharma Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
Table Innovate Biopharma Recent Development
Table Cosmo Pharmaceuticals Company Details
Table Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
Figure Cosmo Pharmaceuticals Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
Table Cosmo Pharmaceuticals Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
Figure Gilead Sciences Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
Table Gilead Sciences Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
Table Pfizer Recent Development
Table Global Inflammatory Bowel Disease Therapy Market Size by Regions (Million US$) 2019-2025
Figure Global Inflammatory Bowel Disease Therapy Market Size Share by Regions (2019-2025)
Figure Global Inflammatory Bowel Disease Therapy Market Size Share by Regions in 2025
Figure North America Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2025)(Million USD)
Figure China Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Japan Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2025)(Million USD)
Figure India Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2025)(Million USD)
Table Global Inflammatory Bowel Disease Therapy Market Size by Product (2019-2025) (Million US$)
Figure Global Inflammatory Bowel Disease Therapy Market Size by Product (2019-2025)
Figure Global Inflammatory Bowel Disease Therapy Market Size by Product in 2025
Table Global Inflammatory Bowel Disease Therapy Market Size by Application (2019-2025) (Million US$)
Figure Global Inflammatory Bowel Disease Therapy Market Size by Application (2019-2025)
Figure Global Inflammatory Bowel Disease Therapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
炎症性腸疾患の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stom…- 炎症性腸疾患治療のグローバル市場調査 2019年 The global Inflammatory Bowel Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Inflammatory Bowel Disease Treatment volume and value at global level, regional level and company leve…
- 関節疾患治療のグローバル市場：規模・現状・予測2019-2025 Joint disease is defined as any type of injury or inflammation or disease that affects the joints of the body. Joint disease can range from acute to very chronic, excruciatingly painful or simply nagging and uncomfortable.In 2018, the global Joint Disease Therapeutics market size was xx million US$ …
- 網膜疾患治療薬のグローバル市場：規模・現状・予測2019-2025 Retinal diseases vary widely, but most of them cause visual symptoms. Retinal diseases can affect any part of your retina, a thin layer of tissue on the inside back wall of your eye.In 2018, the global Retinal Disease Therapeutics market size was xx million US$ and it is expected to reach xx million…
- 性感染症（STD）検査のグローバル市場：規模・現状・予測2019-2025 Sexually Transmitted Disease (STD) Testing is a medical means of testing, prevention, and treatment of Sexually Transmitted Disease (STD).The need for tests that eliminate certain patient and provider barriers, which hamper routine screening, is rising. In line with this, vendors of the global STD t…